Eye health in obese patients using weight-loss injections
Part of Brain & nervous system, Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study looks at whether a type of weight-loss injection (called GLP-1 receptor agonists) may affect the eye's optic nerve in people who are obese but do not have diabetes. It aims to find out if there is any link between these injections and a rare eye condition called NAION (which can cause sudden vision loss).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are obese (BMI over 30)
- You do not have diabetes or high blood pressure
- You have had at least two eye exams with records
- You are not being treated for major depression and are not taking antidepressants
- You can hear, speak, and think clearly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests whether an experimental weight-loss injection can reduce knee pain in people who are obese and have knee osteoarthritis. It may help if you have been unable to lose weight through diet and exercise and have moderate knee pain.
This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
This study tests whether insulin eye drops can help people with glaucoma by protecting the optic nerve. It is an early-stage trial that may offer a new way to manage the condition.
This study looks at how the optic nerve (the part of your eye that sends images to your brain) strains or bends in people who do not have glaucoma. It uses advanced eye imaging and home pressure checks to understand the nerve's health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.